Condition
Cardiac Toxicity clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Cardiac Toxicity clinical trials that are recruiting, at sites in 7 countries (most in United States (2), Poland (2), Italy (1)). By phase: Phase 4 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 7Countries
Newest Cardiac Toxicity clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Evaluating heart health in adult cancer patients treated with cardiotoxic therapies | — | Rome, Lazio | Recruiting | Oct 29, 2024 |
| Stopping heart failure medications in cancer survivors with heart dysfunction | Phase 4 | Los Angeles, California and 13 other locations | Recruiting | Dec 27, 2023 |
| Using statins to reduce heart problems in breast cancer patients receiving HER2 therapy | Phase 2 | Elizabeth, New Jersey and 9 other locations | Recruiting | Sep 29, 2022 |
| Using Sacubitril/Valsartan to prevent heart damage in breast cancer treatment | Phase 4 | Opole, Opole Voivodeship and 3 other locations | Recruiting | Jul 19, 2022 |
All recruiting trials (4)
-
Evaluating heart health in adult cancer patients treated with cardiotoxic therapies
This study is trying to see how heart health is affected in adult cancer patients who have received treatments that might harm their hearts.
-
Stopping heart failure medications in cancer survivors with heart dysfunction
This study is testing if cancer survivors with improved heart function can safely stop taking their heart failure medications to see if it reduces their pill burden and side effects.
-
Using statins to reduce heart problems in breast cancer patients receiving HER2 therapy
This study is testing if adding a cholesterol-lowering medication called Lipitor can help protect the hearts of women with early-stage HER2 positive breast cancer who are getting treatment.
-
Using Sacubitril/Valsartan to prevent heart damage in breast cancer treatment
This study is testing if the medication Sacubitril/Valsartan can help protect the hearts of women undergoing treatment for breast cancer from damage.
Related topics
Quick answers
How many Cardiac Toxicity clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in United States (2 trials), Poland (2 trials), Italy (1 trial), Australia (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.